Mindset Health

+35%

est. 2Y upside i

Series A

Building AI therapeutics for physical health conditions like IBS.

Rank

#1246

Sector

Digital Therapeutics

Est. Liquidity

~4Y

Data Quality

Data: Medium

Moderate upside potential (35% expected) over 2 years, but high risk from stale valuation and severe preference overhang.

Last updated: July 19, 2026

Bull (20%)+126%

Revenue reaches $10M with 5x multiple from IPO window or category leadership. Net of dilution, common upside ~126%.

Base (55%)+28%

Revenue grows to $10M, multiple stays at 3x. Dilution reduces upside to ~28%.

Bear (25%)-22%

Multiple compresses to 2x, valuation ~$20M, barely above preferred stack. Common upside capped by preference, net -21.5%.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

9010%

Total funding $18.3M vs valuation $20.3M, implying 90% preference overhang.

Dilution Risk

high

Likely to raise additional capital within 24 months given cash burn; assume 20% dilution.

Secondary Liquidity

none

No secondary market activity; likely no liquidity options until exit.

Other — 3 roles

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Mindset Health's data — designed to show you've done your homework.

1
“How does Mindset Health's AI differentiate from competitors in digital hypnotherapy?”
2
“What is the current revenue retention rate and subscription churn?”
3
“What is the typical equity grant size and vesting schedule for early employees?”

Our model estimates +35% upside. What do you think?

Anonymous. Do not share material non-public information.

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.